查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599242

獸用感染疾病物市場：按動物類型、產品類型、給藥途徑和分銷管道分類 - 2025-2030 年全球預測

Veterinary Anti-infectives Market by Animal Type (Companion Animal, Livestock), Product Type (Antibacterial, Antifungals, Antivirals), Route of Administration, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年獸用感染疾病物市場價值為38.4億美元，預計2024年將達到42.8億美元，複合年成長率為11.97%，2030年將達到84.7億美元，預計將達到1000萬美元。

獸用感染疾病物市場包括用於預防、控制和治療動物感染疾病的多種藥物。這包括抗生素、抗病毒藥物、抗黴菌藥、抗寄生蟲藥等。維持牲畜健康和生產力、確保食品安全以及為伴同性動物提供最佳護理的需求推動了對獸用感染疾病的需求。這些產品應用於各種最終用途領域，包括畜牧場、獸醫院、水產養殖和伴同性動物收容所。這一市場趨勢受到動物疾病發病率上升、畜牧業產量增加以滿足全球糧食需求以及寵物飼養趨勢（尤其是在新興經濟體）的顯著影響。

主要市場統計
基準年[2023] 38.4億美元
預測年份 [2024] 42.8億美元
預測年份 [2030] 84.7億美元
複合年成長率（%） 11.97%

市場開拓機會源自於藥物開發的進步，特別是頻譜感染疾病和降低細菌抗藥性的藥物的開發。促進負責任地使用抗生素的監管變化也為益生菌和疫苗等替代療法提供了成長途徑。然而，該市場面臨局限性，包括嚴格的監管要求、高昂的市場開拓成本以及對抗生素抗藥性日益成長的擔憂。這些挑戰需要創新療法的開發，以盡量減少對抗藥性細菌的影響。

研究、開發和創新可以集中在提高藥物療效、開發快速診斷工具以減少抗生素濫用，以及探索傳統抗生素的天然或合成替代品。最佳的創新領域是組合藥物配方和改善治療效果的新的給藥機制。了解正在轉向永續性並最大限度地減少環境影響的市場性質對於指導業務策略至關重要。

隨著產業格局變得更加複雜，需要採取多方面的研發方法，強調與產業相關人員、學術界和監管機構的合作，以克服挑戰並有效利用新機會。透過優先考慮精準醫療和綜合農業，企業可以更好地符合市場需求和監管標準，為永續成長鋪平道路。

市場動態：快速發展的獸用感染疾病物市場的關鍵市場洞察

供需的動態交互作用正在改變獸用感染疾病物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 動物保健意識不斷增強
    • 通用感染疾病發生率上升
    • 由於人們對寵物健康的興趣日益濃厚，越來越多的人收養伴同性動物
  • 市場限制因素
    • 獸醫服務成本高
  • 市場機會
    • 各政府機構和動物協會的有利舉措
    • 擴大動物保健領域的研發活動
  • 市場挑戰
    • 與假藥相關的威脅

波特五力：駕馭獸用感染疾病物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解獸用感染疾病物市場的外部影響

外部宏觀環境因素在塑造獸用感染疾病物市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解獸用感染疾病市場競爭狀況

對獸用感染疾病物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣獸用感染疾病市場供應商績效評估

FPNV定位矩陣是評估獸用感染疾病物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪獸用感染疾病物市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對獸用感染疾病物市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高動物保健意識
      • 通用感染疾病發生率上升
      • 隨著對寵物健康的擔憂增加，寵物擁有量不斷增加
    • 抑制因素
      • 獸醫服務成本高
    • 機會
      • 各政府機構和動物協會的積極計劃
      • 擴大動物保健領域的研發活動
    • 任務
      • 與假藥相關的威脅
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依動物類型分類的獸用感染疾病市場

  • 寵物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 魚
    • 家禽
    • 綿羊和山羊
    • 豬

第7章獸用感染疾病市場：依產品類型

  • 抗菌的
    • 頭孢菌素
    • 大環內酯
    • 青黴素
    • 四環黴素
  • 抗真菌藥物
  • 抗病毒藥物

第8章 獸用感染疾病市場：依給藥途徑

  • 注射
  • 口服

第9章獸用感染疾病市場：依通路分類

  • 電子商務
  • 零售藥房
  • 獸醫診所

第10章：美洲獸用感染疾病物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太獸用感染疾病市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲獸用感染疾病市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nutreco NV
  • Perrigo Company PLC
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-2214614768CF

The Veterinary Anti-infectives Market was valued at USD 3.84 billion in 2023, expected to reach USD 4.28 billion in 2024, and is projected to grow at a CAGR of 11.97%, to USD 8.47 billion by 2030.

The veterinary anti-infectives market encompasses a broad range of medications used to prevent, control, and treat infections in animals. This includes antibiotics, antivirals, antifungals, and antiparasitic agents. The necessity for veterinary anti-infectives is driven by the need to maintain the health and productivity of livestock, ensure food safety, and provide optimal care for companion animals. These products are applied across various end-use areas such as livestock farms, veterinary clinics, aquaculture, and companion animal shelters. Growth in this market is significantly influenced by the rising incidence of animal diseases, increasing livestock production to meet global food demand, and the expanding pet ownership trend, especially in emerging economies.

KEY MARKET STATISTICS
Base Year [2023] USD 3.84 billion
Estimated Year [2024] USD 4.28 billion
Forecast Year [2030] USD 8.47 billion
CAGR (%) 11.97%

Opportunities in the market arise from advancements in drug development, particularly in creating broad-spectrum anti-infectives and those with reduced resistance potential. Regulatory changes promoting the responsible use of antibiotics also present growth avenues for alternative therapies such as probiotics and vaccines. However, the market does face limitations, including stringent regulatory requirements, high development costs, and the growing concern over antibiotic resistance. These challenges necessitate innovations in developing novel therapeutics with minimal resistance impact.

Research and innovation can focus on enhancing drug efficacy, developing rapid diagnostic tools to reduce misuse of antibiotics, and exploring natural or synthetic alternatives to traditional antimicrobials. The best areas for innovation could be in the formulation of combination drugs or new delivery mechanisms that improve treatment outcomes. Understanding the market's nature, which is shifting towards sustainability and minimal environmental impact, is vital for guiding business strategies.

The complex landscape of veterinary anti-infectives requires a multifaceted approach to research and development, with emphasis on collaboration between industry players, academia, and regulatory bodies to overcome challenges and harness emerging opportunities effectively. By prioritizing precision medicine and integrated farming practices, businesses can better align with market demands and regulatory criteria, paving the way for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Anti-infectives Market

The Veterinary Anti-infectives Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness regarding animal healthcare
    • Rising incidence of zoonotic diseases
    • Increasing adoption of companion animals with rising concerns to pet wellbeing
  • Market Restraints
    • High cost of veterinary services
  • Market Opportunities
    • Favorable initiatives by various government agencies and animal associations
    • Growing R&D activities in the animal healthcare
  • Market Challenges
    • Threat associated with counterfeit medicines

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Anti-infectives Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Anti-infectives Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Anti-infectives Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Anti-infectives Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Anti-infectives Market

A detailed market share analysis in the Veterinary Anti-infectives Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Anti-infectives Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Anti-infectives Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Anti-infectives Market

A strategic analysis of the Veterinary Anti-infectives Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Anti-infectives Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Perrigo Company PLC, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Anti-infectives Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Animal Type, market is studied across Companion Animal and Livestock. The Companion Animal is further studied across Cat and Dog. The Livestock is further studied across Cattle, Fish, Poultry, Sheep & Goats, and Swine.
  • Based on Product Type, market is studied across Antibacterial, Antifungals, and Antivirals. The Antibacterial is further studied across Cephalosporins, Macrolides, Penicillin, and Tetracyclines.
  • Based on Route of Administration, market is studied across Injectables and Oral.
  • Based on Distribution Channel, market is studied across E-Commerce, Retail Pharmacies, and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness regarding animal healthcare
      • 5.1.1.2. Rising incidence of zoonotic diseases
      • 5.1.1.3. Increasing adoption of companion animals with rising concerns to pet wellbeing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of veterinary services
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable initiatives by various government agencies and animal associations
      • 5.1.3.2. Growing R&D activities in the animal healthcare
    • 5.1.4. Challenges
      • 5.1.4.1. Threat associated with counterfeit medicines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Anti-infectives Market, by Animal Type

  • 6.1. Introduction
  • 6.2. Companion Animal
    • 6.2.1. Cat
    • 6.2.2. Dog
  • 6.3. Livestock
    • 6.3.1. Cattle
    • 6.3.2. Fish
    • 6.3.3. Poultry
    • 6.3.4. Sheep & Goats
    • 6.3.5. Swine

7. Veterinary Anti-infectives Market, by Product Type

  • 7.1. Introduction
  • 7.2. Antibacterial
    • 7.2.1. Cephalosporins
    • 7.2.2. Macrolides
    • 7.2.3. Penicillin
    • 7.2.4. Tetracyclines
  • 7.3. Antifungals
  • 7.4. Antivirals

8. Veterinary Anti-infectives Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectables
  • 8.3. Oral

9. Veterinary Anti-infectives Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. E-Commerce
  • 9.3. Retail Pharmacies
  • 9.4. Veterinary Clinics

10. Americas Veterinary Anti-infectives Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Anti-infectives Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Anti-infectives Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biogenesis Bago SA
  • 2. Boehringer Ingelheim International GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Elanco Animal Health Incorporated
  • 6. Evonik Industries AG
  • 7. Hester Biosciences Limited
  • 8. Huvepharma, Inc.
  • 9. Merck & Co., Inc.
  • 10. Neogen Corporation
  • 11. Nutreco N.V.
  • 12. Perrigo Company PLC
  • 13. Vetoquinol S.A.
  • 14. Virbac S.A.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY ANTI-INFECTIVES MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY ANTI-INFECTIVES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY ANTI-INFECTIVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY ANTI-INFECTIVES MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DOG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE